Strategies to Address Potential Medication Errors for EUA Products for COVID-19
Рет қаралды 497
Күн бұрынSevan Kolejian, PharmD, MBA, BCPPS, team leader for the Division of Medication Error Prevention and Analysis I, discusses examples of medication errors and strategies to address them to increase the safe use of drug products under development for COVID-19 which are related to the product design, labeling, and/or packaging.
Learn More at: www.fda.gov/dr...
_______________________________
FDA CDER’s Small Business and Industry Assistance (SBIA) educates and provides assistance in understanding the regulatory aspects of human drug products & clinical research.
Upcoming Training - www.fda.gov/cd...
SBIA Listserv - public.govdeli...
SBIA 2021 Playlist - • 2021 CDER Small Busine...
SBIA LinkedIn - / cder-small-business-an...
SBIA Training Resources - www.fda.gov/cd...
Twitter - / fda_drug_info
Email - CDERSBIA@fda.hhs.gov
Phone - (301) 796-6707 I (866) 405-5367
U.S. Food and Drug Administration
Рет қаралды 835
U.S. Food and Drug Administration
Рет қаралды 576
U.S. Food and Drug Administration
Рет қаралды 656
U.S. Food and Drug Administration
Рет қаралды 244
U.S. Food and Drug Administration
Рет қаралды 434
FDA D.I.S.C.O. Burst Edition: FDA approval of Keytruda (pembrolizumab) for unresectable advanced ...
U.S. Food and Drug Administration
Рет қаралды 140
FDA D.I.S.C.O. Burst Edition: FDA approval of Tecelra (afamitresgene autoleucel) for unresectable...
U.S. Food and Drug Administration
Рет қаралды 72
U.S. Food and Drug Administration
Рет қаралды 684
U.S. Food and Drug Administration
Рет қаралды 700
U.S. Food and Drug Administration
Рет қаралды 150